KOSTAIVE Powder for dispersion for injection Ref.[114806] Active ingredients: Zapomeran

Source: European Medicines Agency (EU)  Revision Year: 2025  Publisher: Arcturus Therapeutics Europe B.V., Claude Debussylaan 10, 1082 MD Amsterdam, The Netherlands

Product name and form

Kostaive powder for dispersion for injection.

COVID-19 sa-mRNA Vaccine.

Pharmaceutical Form

Powder for dispersion for injection.

White to off-white lyophilised cake or powder.

Qualitative and quantitative composition

This is a multidose vial and must be reconstituted before use.

One vial contains 16 doses of 0.5 mL after reconstitution with 10 mL of sterile sodium chloride 9 mg/mL (0.9%) solution for injection; see sections 4.2 and 6.6.

One dose (0.5 mL) contains 5 micrograms of zapomeran, a COVID-19 self-amplifying messenger RNA (sa-mRNA) (encapsulated in lipid nanoparticles).

Zapomeran is a single-stranded, 5'-capped sa-mRNA replicon, produced using a cell-free in vitro transcription from the corresponding DNA templates encoding a replicase and the spike glycoprotein of the ancestral strain of SARS-CoV-2 with D614G mutation.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Zapomeran

Zapomeran is composed of a self-amplifying mRNA encoding the spike protein of SARS-CoV-2, encapsulated in lipid nanoparticles. The self-amplifying mRNA is designed to produce extra copies of mRNA within the host cells after intramuscular injection, to achieve enhanced expression of the spike protein antigen.

List of Excipients

Di(pentadecan-8-yl)4,4'((((3-(dimethylamino)propyl)thio)carbonyl)azanediyl)dibutyrate (ATX-126)
Cholesterol
1,2-Distearoyl-sn-glycero-3-phosphocholine (DSPC)
1,2-Dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000 (PEG2000-DMG)
Sucrose
Potassium sorbate
Sodium chloride
Trometamol
Poloxamer 188 (contains the antioxidant butylated hydroxytoluene)

Pack sizes and marketing

Powder contained in a vial (type I glass) with a stopper (bromobutyl rubber) and a plastic flip-off cap with seal (aluminum crimp).

Each multidose vial contains 16 doses of 0.5 mL; see section 6.6.

Pack size: 20 multidose vials.

Marketing authorization holder

Arcturus Therapeutics Europe B.V., Claude Debussylaan 10, 1082 MD Amsterdam, The Netherlands

Marketing authorization dates and numbers

EU/1/24/1873/001

Drugs

Drug Countries
KOSTAIVE Lithuania

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.